NVE Corporation (NASDAQ: NVEC) is one of the most unusual public companies in the semiconductor space: a 41-employee micro-cap with extraordinarily high margins, zero debt, and a decades-long fixed dividend. Founded in 1989, the company has carved a durable niche in spintronics — a nanotechnology that exploits electron spin (rather than charge alone) to acquire, store, and transmit information. Its commercially deployed products are magnetic sensors (detecting position, speed, or the presence of metallic objects) and couplers (for data isolation in industrial IoT applications). End markets include factory automation, medical devices, and industrial IoT.
Beyond product revenue, NVEC actively licenses its MRAM (magnetoresistive RAM) spintronics IP to larger semiconductor and memory companies pursuing next-generation non-volatile memory architectures. Contract R&D agreements add a further variable revenue stream. The result is a business that generates gross margins consistently above 77% and net margins in the 57-60% range — extraordinary for any manufacturer.
With a market cap of ~$505M, total assets of $61M (mostly cash and marketable securities), and only $0.9M of total debt (finance leases), NVEC's enterprise value at the current price is substantially below its market cap: approximately $462M EV after adjusting for the ~$43.5M in cash and investments. The stock trades primarily as a high-yield income instrument — the $4.00 annual dividend at $104.50 yields 3.83%.
NVEC's fiscal year ends March 31. The most recent annual filing (FY2026, ending March 31, 2026, filed May 6, 2026) is the data anchor for this report.
Investment Thesis — Income + Niche Optionality
NVEC is best understood as a high-margin specialty technology income vehicle, not a growth stock. Revenue has been range-bound between $25M and $38M over the past five fiscal years, with a peak in FY2023 (~$38M) followed by two years of decline back toward $26M in FY2026. The company does not pursue scale aggressively — it operates with 41 employees and has no meaningful long-term debt.
The core income thesis: NVEC has paid $4.00/share annually in quarterly dividends of $1.00 for many years, funded by high net margins on its sensor/coupler/licensing business and supported by a cash and marketable-securities balance of ~$43.5M (roughly $9/share). The dividend is not covered by FCF in FY2026 ($14.5M FCF vs $19.3M dividends), but the balance sheet buffer is substantial enough to sustain it for multiple years even if FCF stays below the payout level.
The optionality angle: NVEC's spintronics IP could gain relevance if MRAM achieves broader adoption as an alternative to DRAM/NAND in embedded and IoT applications. Sensor and coupler demand tracks factory automation and industrial IoT buildout globally. These are slow-moving, lumpily contracted markets — not a fast revenue ramp — but the niche is defensible and the IP moat is real.
At 52-week highs and 33x trailing earnings, the risk is a re-rating lower if revenue continues to contract or the dividend coverage concern intensifies. The stock doubled from its 52-week low of $57.21 — much of the near-term income value may already be priced in.
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $27.0M | $38.3M | $29.8M | $25.9M | $26.3M |
| Revenue Growth YoY | — | +41.7% | -22.1% | -13.2% | +1.8% |
| Gross Profit | $20.7M | $30.2M | $23.0M | $21.6M | $20.7M |
| Gross Margin | 76.8% | 78.9% | 77.3% | 83.6% | 78.7% |
| Operating Income | $16.3M | $25.6M | $18.5M | $16.0M | $15.9M |
| Operating Margin | 60.5% | 67.0% | 62.1% | 61.8% | 60.5% |
| EBITDA | $16.8M | $25.8M | $18.8M | $16.3M | $16.4M |
| EBITDA Margin | 62.1% | 67.6% | 63.2% | 63.1% | 62.2% |
| Interest Income | $1.2M | $1.4M | $1.9M | $1.9M | $1.9M |
| Net Income | $14.5M | $22.7M | $17.1M | $15.1M | $15.2M |
| Net Margin | 53.8% | 59.3% | 57.5% | 58.2% | 57.7% |
| EPS (Diluted) | $3.00 | $4.70 | $3.54 | $3.11 | $3.14 |
| R&D Expense | $2.9M | $2.6M | $2.7M | $3.6M | $1.1M |
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Cash & ST Investments | $31.3M | $17.2M | $22.2M | $21.7M | $19.8M |
| LT Investments (Mkt Sec.) | $24.3M | $36.1M | $30.8M | $26.3M | $23.7M |
| Total Cash & Investments | $55.6M | $53.3M | $53.0M | $48.0M | $43.5M |
| Net Receivables | $4.7M | $6.5M | $3.1M | $3.6M | $3.9M |
| Inventory | $5.1M | $6.4M | $7.2M | $7.4M | $7.1M |
| Total Assets | $67.5M | $69.3M | $66.8M | $64.3M | $60.9M |
| Total Debt (Finance Leases) | $0.6M | $0.5M | $0.4M | $0.9M | $0.9M |
| Net Debt (Cash Less Debt) | -$9.8M | -$1.2M | -$9.9M | -$7.1M | Net Cash |
| Stockholders' Equity | $64.6M | $67.1M | $65.6M | $62.3M | $58.2M |
| Current Ratio | 16.9x | 16.8x | 32.0x | 28.4x | 28.2x |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $12.5M | $19.1M | $18.2M | $14.3M | $16.7M |
| OCF Margin | 46.3% | 49.9% | 61.2% | 55.3% | 63.3% |
| Capital Expenditures | -$0.5M | -$0.9M | -$0.0M | -$1.3M | -$2.2M |
| Free Cash Flow | $12.0M | $18.2M | $18.2M | $13.1M | $14.5M |
| FCF Margin | 44.5% | 47.5% | 61.1% | 50.5% | 55.1% |
| Dividends Paid | -$19.3M | -$19.3M | -$19.3M | -$19.3M | -$19.3M |
| FCF Less Dividends | -$7.3M | -$1.1M | -$1.1M | -$6.2M | -$4.8M |
| Purchases of Investments | $0 | -$28.4M | -$6.1M | -$11.3M | -$15.2M |
| Maturities of Investments | $7.5M | $20.8M | $15.7M | $15.2M | $13.8M |
| Net Stock Issuance | -$0.2M | $0 | $0.1M | $0.1M | $0 |
| Multiple | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 (curr.) |
|---|---|---|---|---|---|
| P/E Ratio | 18.1x | 17.7x | 25.1x | 20.5x | 33.3x |
| P/S Ratio | 9.8x | 10.5x | 14.4x | 11.9x | 19.2x |
| P/B Ratio | 4.1x | 6.0x | 6.6x | 4.9x | 8.7x |
| P/FCF Ratio | 21.9x | 22.1x | 23.6x | 23.6x | 34.9x |
| EV/EBITDA (net cash adj.) | 15.1x | 15.5x | 22.3x | 18.4x | 28.2x |
| EV/Sales | 9.4x | 10.4x | 14.1x | 11.6x | 17.6x |
| Dividend Yield | 7.3% | 4.8% | 4.5% | 6.3% | 3.83% |
| FCF Yield | 4.6% | 4.5% | 4.2% | 4.2% | 2.9% |
| Dividend / FCF Coverage | 1.6x payout | 1.06x payout | 1.06x payout | 1.48x payout | 1.33x payout |
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Return on Equity (ROE) | 22.5% | 33.8% | 26.1% | 24.2% | 26.1% |
| Return on Assets (ROA) | 21.5% | 32.8% | 25.6% | 23.4% | 25.0% |
| ROIC | 20.8% | 31.8% | 23.5% | 21.1% | 22.7% |
| Gross Margin | 76.8% | 78.9% | 77.3% | 83.6% | 78.7% |
| Operating Margin | 60.5% | 67.0% | 62.1% | 61.8% | 60.5% |
| EBITDA Margin | 62.1% | 67.6% | 63.2% | 63.1% | 62.2% |
| Net Margin | 53.8% | 59.3% | 57.5% | 58.2% | 57.7% |
| Asset Turnover | 0.40x | 0.55x | 0.45x | 0.40x | 0.43x |
| Current Ratio | 16.9x | 16.8x | 32.0x | 28.4x | 28.2x |
| R&D as % of Revenue | 10.8% | 6.8% | 9.2% | 14.1% | 4.2% |
| Metric | FY2025A | FY2026A | FY2027E | FY2028E |
|---|---|---|---|---|
| Revenue (Avg. Est.) | $25.9M | $26.3M (actual) | — | — |
| EPS (Avg. Est.) | $3.11 | $3.14 (actual) | — | — |
| # Analysts (Rev / EPS) | 0 | 0 | 0 | 0 |
| Fwd P/E | N/A | 33.3x (ttm) | No est. | No est. |
| Name | Title | Type | Shares | Price | Date |
|---|---|---|---|---|---|
| Baker Daniel A | President & CEO | Option Award | 2,500 | $90.21 | May 8, 2026 |
| Baker Daniel A | President & CEO | Sale | 1,155 | $74.04 | Jan 27, 2026 |
| Baker Daniel A | President & CEO | Sale | 103 | $72.25 | Jan 29, 2026 |
| Bracke James W | Director | Option Award | 1,000 | $61.72 | Aug 7, 2025 |
| Hollister Patricia M | Director | Option Award | 1,000 | $61.72 | Aug 7, 2025 |
| Wei Xuan Kelly | Director | Option Award | 1,000 | $61.72 | Aug 7, 2025 |
| Bracke James W | Director | Purchase | 100 | $57.97 | Apr 4, 2025 |
Durable income with a fortress balance sheet. NVEC has paid $4.00/share annually for many years without interruption, supported by a $43.5M cash and marketable-securities buffer that represents ~8-9 years of the FCF shortfall at current rates. The dividend is not at risk in any near-term scenario absent a catastrophic revenue collapse. For income-focused investors, a 3.83% yield from a debt-free, high-margin franchise is genuinely attractive.
MRAM optionality is real, if slow-moving. NVEC's MRAM licensing IP sits in front of a potentially large memory technology transition. If MRAM achieves broader adoption in embedded memory, automotive, or IoT applications — displacing SRAM or EEPROM in critical applications — licensing revenue could accelerate materially beyond the $26M product-plus-contract baseline. This is not a near-term catalyst but represents asymmetric upside in a long-tailed scenario.
Factory automation and medical sensor demand are secular tailwinds. Industrial IoT buildout, robotics adoption in manufacturing, and continued medical device miniaturization all drive incremental sensor/coupler demand. NVEC's products are often designed into platforms (not commoditized), creating sticky revenue with long product lifecycles. A recovery of revenue back toward $30-35M would substantially improve FCF-to-dividend coverage and reduce balance sheet drawdown.
Robotics market commentary. Management's Q4 FY2026 earnings call referenced strong outlook for semiconductor and robotics markets — consistent with the industrial automation macro trend. If product revenue re-accelerates in FY2027 toward $30M+, EPS could recover above $4.00, re-establishing dividend coverage from earnings.
Revenue concentration and lumpiness is a real structural risk. NVEC's ~$26M revenue base is highly concentrated — a handful of customers, lumpy contract R&D, and licensing agreements that do not recur predictably. The 31% revenue peak-to-trough decline from FY2023 ($38.3M) to FY2025 ($25.9M) in just two years demonstrates how quickly the top line can fall. If key customers reduce orders or a major licensing agreement expires/lapses, revenue could slip toward $20M, making dividend coverage extremely difficult.
Dividend coverage is already strained. FCF ($14.5M in FY2026) covers only 75% of the $19.3M annual dividend. The company is effectively paying the dividend by liquidating its investment portfolio — a sustainable short-term strategy but a structural problem if FCF doesn't recover. A dividend cut would likely cause a sharp de-rating, as the income thesis is the primary reason institutional holders own the stock.
Micro-cap liquidity risk. At ~90K average daily shares traded, even modest institutional selling creates meaningful price pressure. The stock doubled from its 52-week low in under 12 months — the same thin liquidity that allowed the run-up would amplify any reversal. Bid-ask spreads widen during volatility periods, and exit costs for larger positions are non-trivial.
Valuation has become stretched. At 33x P/E and 28x EV/EBITDA, NVEC is priced as though revenue growth and MRAM monetization are imminent — neither is supported by recent results. A reversion to the historical 18-22x P/E range (where the stock traded 2022-2023) implies a price of $57-$69, which is the 52-week low range. At current prices, the risk/reward for new capital is unfavorable. The GuruFocus analysis (May 22, 2026) labeled the stock "Overvalued" at $91 — it has since run further to $104.
Revenue of ~$26M is concentrated among a small number of customers for sensors, couplers, and contract R&D. NVEC does not disclose customer concentration explicitly, but the FY2023-FY2025 revenue decline of ~32% illustrates how one or two customer decisions can dramatically alter results in a single year. No customer diversification safety net exists at this revenue scale.
The $4.00/yr dividend has exceeded FCF in four of the past five fiscal years. The company funds the shortfall by drawing down its ~$43.5M investment portfolio, depleting ~$5M/yr at the current rate. If revenue does not recover to ~$30M+, the board will face a difficult decision: cut the dividend (likely causing a significant price drop) or continue depleting the balance sheet buffer.
With ~90K average daily volume (~$9M/day at current prices), NVEC is effectively uninvestable for most institutional accounts and carries meaningful execution risk for individual investors with position sizes above ~$100K. The thin float amplifies both upside runs and downside reversals, and market impact costs are real on entry/exit.
NVEC has operated in a $25-38M revenue band for over a decade. The spintronics sensor/coupler TAM is niche by design — the company has not demonstrated ability to grow beyond this range organically. Contract R&D and licensing revenues are episodic and non-recurring, adding a lumpiness that makes year-to-year modeling unreliable. There is no visible path to doubling revenue without a material MRAM licensing acceleration.
Trading at $104.50 vs a 52-week low of $57.21, NVEC has more than doubled and now trades at 33x P/E — the highest P/E multiple in the observed 5-year history. The dividend yield of 3.83% is at the low end of the historical range (4.5-7.3%), suggesting the stock is pricing in optimistic assumptions. Reversion to mean yield implies a share price of $55-$89 — a material downside from current levels.
MRAM has been a "next-generation memory" technology for over a decade, with commercial adoption slower than proponents projected. NVEC's licensing revenue depends on the pace at which large semiconductor companies commercialize MRAM at scale. A continued slow adoption cycle means licensing income remains episodic and modest, not a growth driver. Competition from STT-MRAM and SOT-MRAM developed by larger players (Samsung, Everspin) could also reduce the value of NVEC's licensing IP over time.
Revenue recovers to $30-33M in FY2027, driven by factory automation / robotics demand and a new licensing agreement. EPS rebounds to $3.80-$4.20, restoring dividend-from-earnings coverage. The market re-rates on the dividend-covered narrative: yield compresses to 3.2-3.5% (stock ~$115-$125). EV/EBITDA stays elevated at 28-32x on improved EBITDA of ~$19-20M. Bull trigger: FY2027 Q1-Q2 revenue acceleration confirmed in earnings. The $43.5M cash buffer provides a floor against any near-term dividend disruption.
Revenue flat at $26-28M in FY2027. EPS holds at $3.00-$3.30. The stock gradually re-rates from 33x toward its historical 25-28x P/E range as no near-term catalyst materializes. At 27x P/E on $3.15 EPS: ~$85. Dividend yield re-rates toward 4.5-4.7%: implies ~$85-$89. The balance sheet drawdown continues at ~$5M/yr, but the $43.5M buffer remains comfortable. Investors receive the 3.83% yield plus/minus price return of -5 to -15%. Base trigger: earnings in FY2027 confirm revenue stability but no growth acceleration. Chuck Royce reduction is a soft leading indicator of the base scenario playing out.
Revenue declines to $20-23M (repeating or exceeding the FY2023-FY2025 decline trajectory). FCF falls to $8-10M, widening the dividend deficit to $9-11M/yr. The board cuts the dividend from $4.00 to $2.00-$2.50 to preserve the balance sheet. A dividend cut causes rapid re-rating: at a 3.5-4% yield on $2.25 dividends, the stock prices to $56-$64. Even at the cut price, EV/EBITDA would be 18-22x on $12-14M EBITDA — more reasonable historically. Bear trigger: one or more major customers reduce orders significantly, or a key licensing agreement lapses without renewal. Micro-cap illiquidity amplifies the drawdown.
This report was generated using FMP financial data as of June 5, 2026. This is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results. NVEC is a micro-cap stock with limited analyst coverage and thin trading liquidity — position sizing should reflect these constraints.